Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Breast Journal|January 18, 2006
Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence ratesCharles Kunos, Larry Latson, Beth Overmoyer, et al.
American Journal of Obstetrics and Gynecology|January 2, 2008
Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative studyFrancesca Martra, Charles Kunos, Heidi Gibbons, et al.
Technology in Cancer Research & Treatment|September 17, 2009
Stereotactic body radiosurgery for pelvic relapse of gynecologic malignanciesCharles Kunos, William Chen, Robert DeBernardo, et al.
Journal of Translational Medicine|May 1, 2012
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group StudyCharles Kunos, Tomas Radivoyevitch, Fadi W Abdul-Karim, et al.
Technology in Cancer Research & Treatment|September 12, 2008
Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapyCharles Kunos, Vivian von Gruenigen, Steven Waggoner, et al.
Expert Review of Anticancer Therapy|August 3, 2011
Emerging application of stereotactic body radiation therapy for gynecologic malignanciesNina A Mayr, Zhibin Huang, Jason W Sohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing RadiationTimothy Kinsella, Howard Safran, Susan Wiersma, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2021
National Cancer Institute support for targeted alpha-emitter therapyJulie A Hong, Martin Brechbiel, Jeff Buchsbaum, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 8, 2017
LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasmaJulia Matsumoto, Brian F Kiesel, Robert A Parise, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group studyCharles Kunos, Wei Deng, Dawn Dawson, et al.
Pageof 4